Edition:
United States

Meridian Bioscience Inc (VIVO.OQ)

VIVO.OQ on NASDAQ Stock Exchange Global Select Market

12.95USD
4:00pm EDT
Change (% chg)

$0.15 (+1.17%)
Prev Close
$12.80
Open
$12.80
Day's High
$13.00
Day's Low
$12.70
Volume
98,948
Avg. Vol
102,071
52-wk High
$21.49
52-wk Low
$10.77

Latest Key Developments (Source: Significant Developments)

Meridian Bioscience Inc signs an exclusive distribution agreement with Biofirm Technologies
Tuesday, 7 Mar 2017 09:17am EST 

Meridian Bioscience Inc :Meridian Bioscience Inc- Magellan Diagnostics , a business unit signed an exclusive distribution agreement with Biofirm Technologies.  Full Article

Meridian Bioscience Q1 earnings per share $0.15
Wednesday, 25 Jan 2017 07:30am EST 

Meridian Bioscience Inc : Meridian Bioscience reports first quarter 2017 operating results, reduces regular cash dividend, and revises fiscal 2017 guidance downward . Q1 earnings per share $0.15 . Q1 revenue $46.8 million versus I/B/E/S view $51.1 million . Q1 earnings per share view $0.20 -- Thomson Reuters I/B/E/S . Sees FY 2017 earnings per share $0.64 to $0.69 . Sees FY 2017 revenue $193 million to $199 million . Meridian Bioscience Inc - revised fiscal 2017 annual indicated cash dividend rate to $0.50 per share . Fy2017 earnings per share view $0.82, revenue view $206.1 million -- Thomson Reuters I/B/E/S .Meridian Bioscience Inc - "taking further action to align resources, reduce expenses and optimize investments in product development".  Full Article

Meridian Bioscience says Magellan Diagnostics signed exclusive distribution agreement with Medcaptain Medical Technology
Tuesday, 20 Dec 2016 02:00pm EST 

Meridian Bioscience Inc - : Meridian Bioscience Inc- Magellan Diagnostics business unit has signed an exclusive distribution agreement with Medcaptain Medical Technology Co., Ltd .Meridian Bioscience Inc - Distribution activities with Medcaptain will begin in January 2017.  Full Article

Meridian Bioscience reports Q3 EPS of $0.21
Thursday, 28 Jul 2016 08:00am EDT 

Meridian Bioscience Inc : Meridian Bioscience reports third quarter 2016 operating results, declares regular cash dividend, and updates fiscal 2016 guidance . FY 2016 earnings per share view $0.88, revenue view $203.4 million -- Thomson Reuters I/B/E/S . Sees FY 2016 NON-GAAP earnings per share $0.86 to $0.90 . Q3 earnings per share $0.21 . Sees FY 2016 revenue $195 million to $200 million . Q3 earnings per share view $0.22 -- Thomson Reuters I/B/E/S .Q3 revenue $50.7 million versus I/B/E/S view $52.8 million.  Full Article

Meridian Bioscience Inc acquires Magellan Diagnostics Inc
Thursday, 24 Mar 2016 04:15pm EDT 

Meridian Bioscience Inc:Has completed the acquisition of Magellan Biosciences Inc and its wholly owned subsidiary Magellan Diagnostics Inc.Expects Magellan to be accretive to earnings per share during the second half of calendar 2017.Says Meridian will finance purchase price of $66 million using a combination of cash on hand and a $60 million five-year term loan.  Full Article

Meridian Bioscience Inc reaffirms FY 2016 guidance
Wednesday, 27 Jan 2016 07:30am EST 

Meridian Bioscience Inc:Reaffirms FY 2016 2016 guidance of per share diluted earnings between $0.86 and $0.90 on net revenues of $195 million to $200 million.  Full Article

Meridian Bioscience announces investment in Oasis Diagnostics
Thursday, 12 Nov 2015 03:00pm EST 

Meridian Bioscience Inc:Announced that it has made a minority investment in Oasis Diagnostics Corporation, with the right to acquire Oasis in the future.Says terms of the transaction were not disclosed.  Full Article

Meridian Bioscience Inc declares regular cash dividend
Thursday, 5 Nov 2015 07:30am EST 

Meridian Bioscience Inc:Declared the regular quarterly cash dividend of $0.20 per share for the fourth quarter ended September 30.Says dividend is of record date of November 16 and payable November 27.  Full Article

Meridian Bioscience Inc declares regular quarterly cash dividend
Sunday, 26 Jul 2015 08:00am EDT 

Meridian Bioscience Inc:Declares regular quarterly cash dividend of $0.20 per share for third quarter ended June 30.Says dividend is of record Aug. 3, and payable Aug. 13.  Full Article

Meridian Bioscience Inc reaffirms FY 2015 guidance
Thursday, 23 Jul 2015 08:00am EDT 

Meridian Bioscience Inc:Sees FY 2015 revenues to be in the range of $193 million to $200 million.Sees FY 2015 per share diluted earnings to be between $0.85 and $0.91.  Full Article

More From Around the Web

BRIEF-Meridian Bioscience Inc signs an exclusive distribution agreement with Biofirm Technologies

* Meridian Bioscience Inc- Magellan Diagnostics , a business unit signed an exclusive distribution agreement with Biofirm Technologies Source text for Eikon: Further company coverage: